Vertigo Clinical Trials

Find Vertigo Clinical Trials Near You

Evaluation of Autonomic Function Using Short-Term Heart Rate Variability in Patients With Benign Paroxysmal Positional Vertigo: A Prospective Case-Control Study

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder. Although the pathophysiology of BPPV is mainly attributed to the displacement of otoconia within the semicircular canals, recent studies suggest that psychological stress and anxiety may be associated with the onset or recurrence of the disease. However, the biological mechanisms underlying this relationship remain poorly understood, and objective evaluation of autonomic nervous system function in patients with BPPV is limited. Heart rate variability (HRV) is a non-invasive method widely used to assess autonomic nervous system activity. Short-term HRV measurements provide information about autonomic balance and vagal tone. In particular, parameters such as the root mean square of successive differences (RMSSD) and the coefficient of variation of RR intervals (COV RR/R) are considered indicators of parasympathetic activity. The aim of this prospective case-control study is to evaluate vagal tone in patients with BPPV using short-term HRV analysis and to compare the findings with age-, sex-, and body mass index-matched healthy controls. Participants will undergo standardized HRV measurements at rest and during controlled breathing. Perceived stress levels will also be assessed using the Perceived Stress Scale (PSS-10). The primary outcomes of the study are RMSSD and the coefficient of variation of RR intervals (COV RR/R), obtained from short-term HRV recordings. These parameters will be compared between BPPV patients and healthy controls, and their associations with perceived stress levels will also be explored. The findings of this study may provide insights into the role of autonomic regulation and stress-related mechanisms in the pathophysiology of BPPV.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: t
View:

• BPPV Group

⁃ Age 18 years or older

⁃ Clinical diagnosis of benign paroxysmal positional vertigo (BPPV) confirmed by positional testing (Dix-Hallpike and/or Roll test) with positional nystagmus

⁃ No known history of cardiac disease

⁃ Ability and willingness to provide written informed consent

⁃ Healthy Control Group

⁃ Age 18 years or older

⁃ No history of vertigo or known vestibular disorder

⁃ Age- and sex-matched to the BPPV group

⁃ No known history of cardiac disease

⁃ Ability and willingness to provide written informed consent

Locations
Other Locations
Turkey
Medicalpark Florya Hospital
RECRUITING
Istanbul
Contact Information
Primary
Dastan Temirbekov, assistan professor
dasekeeee@gmail.com
05314013014
Time Frame
Start Date: 2026-04-01
Estimated Completion Date: 2026-09-01
Participants
Target number of participants: 104
Treatments
BPPV Group
Patients diagnosed with benign paroxysmal positional vertigo (BPPV) based on positional testing in the otolaryngology clinic.
Healthy Control Group
Age-, sex-, and body mass index-matched healthy volunteers without a history of vestibular disorders
Sponsors
Leads: Istanbul Aydın University

This content was sourced from clinicaltrials.gov

Similar Clinical Trials

We couldn't find any related articles check for more on the main search page.